SP
BravenNow
ICU Medical extends executive severance plan expiration to December 2028
| USA | economy | ✓ Verified - investing.com

ICU Medical extends executive severance plan expiration to December 2028

#ICU Medical #Executive Severance Plan #NASDAQ:ICUI #KeyBanc #Medical Devices #SEC Filing #Corporate Governance #Price Target

📌 Key Takeaways

  • ICU Medical extended Executive Severance Plan expiration by three years to December 31, 2028
  • The amendment was approved by the Board of Directors' Compensation Committee and filed with the SEC
  • KeyBanc raised ICU Medical's price target to $180 while maintaining an Overweight rating
  • Analysts expect steady revenue growth and margin expansion opportunities for the company

📖 Full Retelling

ICU Medical, Inc. (NASDAQ:ICUI) announced on Friday, February 20, 2026, that its Board of Directors' Compensation Committee has approved an amendment extending the expiration date of its Executive Severance Plan from December 31, 2025 to December 31, 2028, providing continued severance arrangements for executives under certain circumstances. The Third Amendment to the plan was filed as an exhibit to the company's Form 8-K with the Securities and Exchange Commission. ICU Medical, a manufacturer of medical devices incorporated in Delaware with principal executive offices in San Clemente, California, had previously amended the Executive Severance Plan on December 31, 2019. The extension comes as the company has recently gained positive attention from financial analysts, with KeyBanc raising its price target for ICU Medical to $180 from $175 while maintaining an Overweight rating. KeyBanc's positive assessment follows meetings with ICU Medical's CEO, Vivek Jain, and reflects expectations for steady revenue growth trends and margin expansion opportunities. The firm believes the company is well-positioned for 2026 and considers its initial outlook for that year achievable.

🏷️ Themes

Corporate Governance, Financial Performance, Healthcare Industry

📚 Related People & Topics

SEC filing

SEC filing

Type of financial statements in the United States

# SEC Filing An **SEC filing** is a formal financial statement or regulatory document submitted to the **U.S. Securities and Exchange Commission (SEC)**. These filings are mandatory requirements designed to ensure transparency, providing a standardized method for disclosing material information to ...

View Profile → Wikipedia ↗

ICU Medical

Medical technology company

ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs.

View Profile → Wikipedia ↗
Medical device

Medical device

Device to be used for medical purposes

A medical device is any device intended to be used for medical purposes. Significant potential for hazards are inherent when using a device for medical purposes and thus medical devices must be proved safe and effective with reasonable assurance before regulating governments allow marketing of the d...

View Profile → Wikipedia ↗

Entity Intersection Graph

Connections for SEC filing:

🌐 Restricted stock 8 shared
🌐 Insider trading 6 shared
🌐 SEC 3 shared
👤 New York Stock Exchange 3 shared
🏢 Nvidia 2 shared
View full profile

Deep Analysis

Why It Matters

Extending the executive severance plan to 2028 gives ICU Medical’s top leaders longer-term security and may influence future compensation negotiations. The change signals management confidence and can affect investor perception of governance and cost structure.

What Happens Next

The plan will remain in effect until December 31, 2028, providing executives with continued severance protection. Investors will likely monitor the company’s financial performance and any future amendments that may occur as the plan’s expiration approaches.

Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Trump imposes new 10% global levy as SCOTUS strikes down sweeping tariffs Gold rises, silver jumps after disappointing economic data, SCOTUS tariff ruling Stocks end higher after SCOTUS tariff ruling, S&P 500 snaps two-week losing streak U.S. military operation in Iran "likely at this stage," Raymond James says (South Africa Philippines Nigeria) ICU Medical extends executive severance plan expiration to December 2028 By Investing.com SEC Filings Published 02/20/2026, 07:54 PM ICU Medical extends executive severance plan expiration to December 2028 0 ICUI 5.05% ICU Medical, Inc. (NASDAQ:ICUI) announced that its Board of Directors’ Compensation Committee has approved an amendment to the company’s Executive Severance Plan. According to a press release statement and a filing with the Securities and Exchange Commission, the amendment, adopted on Friday, extends the expiration date of the Executive Severance Plan by three years, moving it from December 31, 2025, to December 31, 2028. The change was made effective as of December 31, 2025. The Executive Severance Plan, which provides severance arrangements for executives under certain circumstances, was previously amended on December 31, 2019. The latest amendment, identified as the Third Amendment to the plan, was filed as an exhibit to the company’s Form 8-K. ICU Medical is a manufacturer of medical devices and is incorporated in Delaware, with its principal executive offices in San Clemente, California. The company’s common stock is traded on The Nasdaq Stock Market LLC under the symbol ICUI. All information in this article is based on the company’s press release statement and SEC filing made Friday. In other recent news, ICU Medical has caught the attention of analysts with developments in its financial outlook. KeyBanc has raised its price target for ICU Medical to $180 from a previous $175, maintaining an Overweight rating. This decision comes as the firm antic...
Read full article at source

Source

investing.com

More from USA

News from Other Countries

🇬🇧 United Kingdom

🇺🇦 Ukraine